Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Breaking News
Fire breaks out at Kinlaw's Supermarket in Fayetteville, emergency crews respond
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Theravance Bio Ord
(NQ:
TBPH
)
8.800
+0.180 (+2.09%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Theravance Bio Ord
< Previous
1
2
3
4
5
6
Next >
Earnings Preview: Theravance Biopharma
February 24, 2023
Via
Benzinga
Target To Rally 29%? Plus This Analyst Predicts $245 For IQVIA Holdings
November 17, 2022
Piper Sandler boosted the price target on Target Corporation (NYSE: TGT) from $190 to $200. Target shares fell 13.1% to close at $155.47 on Wednesday.
Via
Benzinga
Earnings Scheduled For November 7, 2022
November 07, 2022
Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is expected to report quarterly earnings at $0.13 per share on revenue of $36.34 million.
Via
Benzinga
A Preview Of Theravance Biopharma's Earnings
November 04, 2022
Theravance Biopharma (NASDAQ:TBPH) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Here's Why Theravance Biopharma Shares Are Moving
September 19, 2022
Theravance Biopharma Inc (NASDAQ: TBPH) shares are trading higher by 2.78% to $10.35 Monday afternoon after the company authorized a $250 million capital return program. What Else?
Via
Benzinga
Theravance Outlines $250M Capital Return Program; To Repurchase GSK's Entire Holdings
September 19, 2022
Via
Benzinga
Looking Into Theravance Biopharma's Return On Capital Employed
August 24, 2022
According to data from Benzinga Pro, during Q2, Theravance Biopharma's (NASDAQ:TBPH) reported sales totaled $11.05 million. Despite a 68.43% increase in earnings, the company posted a loss of $8.19...
Via
Benzinga
Theravance Biopharma's Earnings: A Preview
August 03, 2022
Theravance Biopharma (NASDAQ:TBPH) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Why Is Conagra Brands Dropping By More Than 8%? 43 Stocks Moving In Thursday's Mid-Day Session
July 14, 2022
Gainers Shineco, Inc. (NASDAQ: SISI) shares climbed 24.5% to $1.2201 on heavy volume.
Via
Benzinga
The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures
July 14, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
July 14, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
July 14, 2022
We're diving into all the latest stock market news with a breakdown of the biggest pre-market stock movers for Thursday!
Via
InvestorPlace
Why Is Ericsson Down By 9%? 22 Stocks Moving In Thursday's Pre-Market Session
July 14, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 22.1% to $0.2050 in pre-market trading. Allena Pharmaceuticals disclosed a new meeting date and new record date for special meeting to approve...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
July 13, 2022
Gainers
Via
Benzinga
Theravance Biopharma, Innoviva Gain On Selling TRELEGY ELLIPTA Royalty Interests
July 13, 2022
Via
Benzinga
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
May 05, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2022
May 23, 2022
Via
Benzinga
Theravance Biopharma's Earnings Outlook
May 04, 2022
Theravance Biopharma (NASDAQ:TBPH) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Theravance Biopharma's Ampreloxetine Shows Benefit In Atrophy Patients, But Not In Parkinson's
April 05, 2022
Theravance Biopharma Inc (NASDAQ: TBPH)
Via
Benzinga
The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel
April 05, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Why Theravance Biopharma Stock Is Trading Lower After Hours
April 04, 2022
Theravance Biopharma Inc (NASDAQ: TBPH) shares are trading lower in Monday's after-hours session after the company announced the results from Study 0170 showed the...
Via
Benzinga
World Markets News For Friday
March 18, 2022
Buoyant global markets are closing the week and one good performer, Vir Biotech, today gained an impressive 6.09%.
Via
Talk Markets
Red Ink
February 24, 2022
There is little joy in stocks today as even companies reporting good results are being hit by fear of Ukraine sanctions.tbph
Via
Talk Markets
Recap: Theravance Biopharma Q4 Earnings
February 24, 2022
Theravance Biopharma (NASDAQ:TBPH) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM. Here's what investors need to know about the...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 23, 2022
Gainers SCYNEXIS (NASDAQ:SCYX) shares inc...
Via
Benzinga
Give peace a chance
February 15, 2022
Israeli fabless semiconductor maker Tower was bought by Intel for $5.4 bn today.
Via
Talk Markets
Nuclear Winter
February 11, 2022
Mexico is raising interest rates to 6%, from 5.5%.
Via
Talk Markets
Earnings Scheduled For February 23, 2022
February 23, 2022
Companies Reporting Before The Bell • Sapiens Intl Corp (NASDAQ:SPNS) is likely to report earnings for its fourth quarter. • Plymouth Industrial REIT (NYSE:PLYM)...
Via
Benzinga
The Last Day In January
January 31, 2022
The market is suspicious of the moves up to right matters.
Via
Talk Markets
More Serious Matters
January 14, 2022
Wall Street fell on new worries about inflation and a drop in retail sales levels.
Via
Talk Markets
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.